Page last updated: 2024-08-21

dihydroergotamine and aprepitant

dihydroergotamine has been researched along with aprepitant in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Chou, DE; Goadsby, PJ; Tso, AR1

Reviews

1 review(s) available for dihydroergotamine and aprepitant

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

1 other study(ies) available for dihydroergotamine and aprepitant

ArticleYear
Aprepitant for the management of nausea with inpatient IV dihydroergotamine.
    Neurology, 2016, Oct-11, Volume: 87, Issue:15

    Topics: Administration, Intravenous; Administration, Oral; Analgesics, Non-Narcotic; Antiemetics; Aprepitant; Dihydroergotamine; Humans; Inpatients; Migraine Disorders; Morpholines; Nausea; Prospective Studies; Retrospective Studies; Treatment Outcome

2016